Could Cerenis Therapeutics Holding SA's (EPA:CEREN) Investor Composition Influence The Stock Price?

Want to participate in a short research study? Help shape the future of investing tools and you could win a $250 gift card!

The big shareholder groups in Cerenis Therapeutics Holding SA (EPA:CEREN) have power over the company. Institutions often own shares in more established companies, while it's not unusual to see insiders own a fair bit of smaller companies. I quite like to see at least a little bit of insider ownership. As Charlie Munger said 'Show me the incentive and I will show you the outcome.'

Cerenis Therapeutics Holding is not a large company by global standards. It has a market capitalization of €7.3m, which means it wouldn't have the attention of many institutional investors. In the chart below below, we can see that institutions are noticeable on the share registry. We can zoom in on the different ownership groups, to learn more about CEREN.

See our latest analysis for Cerenis Therapeutics Holding

ENXTPA:CEREN Ownership Summary, May 28th 2019
ENXTPA:CEREN Ownership Summary, May 28th 2019

What Does The Institutional Ownership Tell Us About Cerenis Therapeutics Holding?

Institutions typically measure themselves against a benchmark when reporting to their own investors, so they often become more enthusiastic about a stock once it's included in a major index. We would expect most companies to have some institutions on the register, especially if they are growing.

We can see that Cerenis Therapeutics Holding does have institutional investors; and they hold 5.4% of the stock. This can indicate that the company has a certain degree of credibility in the investment community. However, it is best to be wary of relying on the supposed validation that comes with institutional investors. They too, get it wrong sometimes. If multiple institutions change their view on a stock at the same time, you could see the share price drop fast. It's therefore worth looking at Cerenis Therapeutics Holding's earnings history, below. Of course, the future is what really matters.

ENXTPA:CEREN Income Statement, May 28th 2019
ENXTPA:CEREN Income Statement, May 28th 2019

We note that hedge funds don't have a meaningful investment in Cerenis Therapeutics Holding. While there is some analyst coverage, the company is probably not widely covered. So it could gain more attention, down the track.

Insider Ownership Of Cerenis Therapeutics Holding

The definition of company insiders can be subjective, and does vary between jurisdictions. Our data reflects individual insiders, capturing board members at the very least. Management ultimately answers to the board. However, it is not uncommon for managers to be executive board members, especially if they are a founder or the CEO.

Most consider insider ownership a positive because it can indicate the board is well aligned with other shareholders. However, on some occasions too much power is concentrated within this group.